Skip to main content
Smart Investors Daily
NH

AMEX · NHS

Neuberger Berman High Yield Strategies Fund Inc.

Financial Services · Asset Management

$5.39

Up+$0.05 (+0.83%)

Updated Oct 6, 2026, 8:59 PM

SID Score

3.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
223.83M
P/E ratio
11.87
Dividend yield
21.94%
52-week range
$5.36 – $7.57
Volume
271.71K
Avg. volume
189.3K

Price performance · NHS

NHS price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 5, 2026

NHS closed at $5.39 after 20 trading sessions, down 8.80% for the selected period.

Last close
$5.39
Period change
-8.80%
Period low
$5.39
Period high
$5.91
Daily close
View OHLC price history
NHS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 5, 2026$5.42$5.42$5.37$5.39271.71K
Oct 2, 2026$5.46$5.47$5.43$5.44182.55K
Oct 1, 2026$5.46$5.47$5.36$5.42345.72K
Sep 30, 2026$5.46$5.49$5.41$5.42444.5K
Sep 29, 2026$5.42$5.46$5.39$5.43288.33K
Sep 28, 2026$5.47$5.4701$5.37$5.40383.23K
Sep 25, 2026$5.44$5.485$5.42$5.47222.21K
Sep 24, 2026$5.46$5.495$5.435$5.44148.29K
Sep 23, 2026$5.55$5.5596$5.47$5.47485.36K
Sep 22, 2026$5.60$5.63$5.56$5.57648.86K
Sep 21, 2026$5.67$5.68$5.605$5.63287.59K
Sep 18, 2026$5.67$5.675$5.645$5.67258.33K
Sep 17, 2026$5.64$5.68$5.635$5.67229.16K
Sep 16, 2026$5.67$5.67$5.59$5.64455.34K
Sep 15, 2026$5.68$5.68$5.6201$5.66283.13K
Sep 14, 2026$5.85$5.85$5.75$5.79477.27K
Sep 11, 2026$5.91$5.91$5.85$5.85114.91K
Sep 10, 2026$5.91$5.916$5.87$5.88125.11K
Sep 9, 2026$5.93$5.93$5.90$5.91172.97K
Sep 8, 2026$5.92$5.929$5.91$5.91103.17K

Latest NHS news

The latest Smart Investors Daily articles mentioning NHS.

NHS research

Overview

Company profile and research snapshot.

Company profile

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · Jan 18, 2026

NHS: Dividend Isn't Supported By Earnings

Neuberger High Yield Strategies' 14.9% yield is attractive, but net investment income consistently falls short of distributions. Read more on NHS CEF here.

Yahoo · Dec 31, 2025

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on January 30, 2026, has a record date of January 15, 2026, and has an ex-date of January 15, 2026.

businesswire.com · Dec 10, 2025

Barking, Havering and Redbridge University Hospitals NHS Trust selects Wolters Kluwer's UpToDate Enterprise Edition to advance clinical decision-making and patient care

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT), an acute care provider serving East London and Essex, has adopted UpToDate® Enterprise Edition. The market-leading clinical decision support (CDS) system will help healthcare administrators and clinicians deliver consistently high-quality care across the Trust which is recognized as a center of excellence in neuroscience, stroke care, and maternity.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.